Worth reading
45Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
11.9
% (year-on-year decline in operating income)Wording
Conditional
How definitive the wording is.Results for this period
First quarter2024年9月1日〜2024年11月30日ConsolidatedJapanese GAAPNet Sales3,210¥ millionYear on year +5.3%Progress 18.3%
Operating profit579¥ millionYear on year -11.9%Progress 14.2%
Ordinary income601¥ millionYear on year -11.0%Progress 14.4%
Net income attributable to owners of the parent413¥ millionYear on year -11.0%Progress 14.3%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share13.18円
Financial position at period-end
Total assets44,130¥ million
of which net assets 40,665 ¥ millionEquity ratio 92.1%vs. prior year-end +0.7pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥17,500 million (YoY +6.6%)
Operating profit¥4,082 million (YoY +1.9%)
Ordinary income¥4,175 million (YoY +2.5%)
Net income¥2,883 million (YoY +2.2%)
Annual Dividend Forecast¥60 → ¥60（0.0%）
Factors Behind Changes in Business Performance
ヘルスケアウェアは期ズレ更新物件を中心に受注が進み9.4％増となった。原材料費の高騰、国内工場の加工賃上昇、円安による原価上昇、人件費の増加などにより利益が減少した。
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Yesそれ以外の変更 No見積りの変更 No修正再表示 No
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Loss on disposal and sale of non-current assets ¥30 thousand
Depreciation and amortization¥67,781 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNo
Issued Shares at Period-End35,736,000
Treasury Shares at Period-End4,490,053
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2024年9月1日〜2024年11月30日 |
| Net Sales | ¥3,210 million (YoY +5.3%) |
| Operating profit | ¥579 million (YoY -11.9%) |
| Ordinary income | ¥601 million (YoY -11.0%) |
| Profit attributable to owners of the parent | ¥413 million (YoY -11.0%) |
| Net income per share | 13.18円 |
| Equity ratio | End of the current fiscal period 92.1 / End of previous period 91.4 |
| Total assets | ¥44,130 million |
| Net assets | ¥40,665 million |
| Full-year earnings forecast | Net Sales ¥17,500 million (YoY +6.6%) / Operating profit ¥4,082 million (YoY +1.9%) / Ordinary income ¥4,175 million (YoY +2.5%) / Net income ¥2,883 million (YoY +2.2%) |
| Annual Dividend Forecast | ¥60 → ¥60（0.0%） |
| Depreciation and amortization | ¥67,781 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Loss on disposal and sale of non-current assets ¥30 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate No / Restatement No |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 35,736,000 |
| Treasury Shares at Period-End | 4,490,053 |
| Factors Behind Changes in Business Performance | ヘルスケアウェアは期ズレ更新物件を中心に受注が進み9.4％増となった。原材料費の高騰、国内工場の加工賃上昇、円安による原価上昇、人件費の増加などにより利益が減少した。 |
Items this document does not state (15)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment lossChanges in the scope of consolidationMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.売上高は、期ズレ更新物件を中心にヘルスケアウェアの受注が進んだことで増加した。一方、営業利益は原材料費や国内工場の加工賃、円安による原価上昇に加え、賃金引き上げや中途採用活動の強化による人件費増加の影響を受けた。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.